Canaccord lowered the firm’s price target on Illumina (ILMN) to $115 from $135 and keeps a Hold rating on the shares. The firm’s target reduction reflects the uncertainty in China as the company is not permitted to export sequencing instruments into China. Illumina then lowered its 2025 guidance for non-GAAP diluted EPS to about $4.50 from a range of $4.50-4.65, given the China headwinds.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN: